Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06522737
PHASE3

A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

Sponsor: SecuraBio

View on ClinicalTrials.gov

Summary

The study will evaluate the progression-free survival benefit of duvelisib monotherapy as compared to investigator's choice of gemcitabine or bendamustine in participants with relapsed/refractory nodal T cell lymphoma with TFH phenotype.

Official title: A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

124

Start Date

2025-05-19

Completion Date

2028-12

Last Updated

2026-04-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

Duvelisib

oral capsules

DRUG

Gemcitabine

solution for intravenous infusion

DRUG

Bendamustine

solution for intravenous infusion

Locations (44)

Universitair Ziekenhuis Gent (UZ Gent)

Ghent, Belgium

UZ Leuven - Gasthuisberg Campus

Leuven, Belgium

Vseobecna fakultni nemocnice

Prague, Czechia

Aarhus University Hospital

Aarhus, Denmark

Rigshospitalet Copenhagen

Copenhagen, Denmark

Odense Hospital

Odense, Denmark

UNICANCER - Centre Henri-Becquerel

Rouen, Normandy, France

Institut Gustave Roussy

Villejuif, Vaillant, France

CHU Cote de Nacre

Caen, France

CHU Clermont-Ferrand

Clermont-Ferrand, France

CHU Montpellier

Montpellier, France

CHU Nantes

Nantes, France

Hopital Pitie Salpetriere

Paris, France

CHU Bordeaux

Pessac, France

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

CHU PONTCHAILLOU-Haematology

Rennes, France

Institut Curie Paris

Saint-Cloud, France

Evangelisches Krankenhaus Essen-Werden

Essen, Germany

Universitaetsmedizin Goettingen (UMG) - Klinik fuer Haematologie und Medizinische Onkologie

Goettigen, Germany

Universitaetsklinikum Halle (Saale)

Halle, Germany

Universitaetsklinikum Leipzig- Klinik und Poliklinik fuer Haematologie und Zelltherapie

Leipzig, Germany

Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo - Alessandria

Alessandria, Italy

Asst Papa Giovanni Xxiii Uo Ematologia

Bergamo, Italy

Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy

Ematologia Oncologia Instituto Pascale

Naples, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, Italy

Amsterdam UMC location AMC

Amsterdam, Netherlands

Leiden University Medical Center (LUMC)

Leiden, Netherlands

Erasmus University Medical Center

Rotterdam, Netherlands

Uniwersyteckie Centrum Kliniczne Oddzial Hematologii i Transplantologii

Gdansk, Poland

Pratia Centrum Medyczne Krakow

Krakow, Poland

Instytut Hematologii i Transfuzjologii

Warsaw, Poland

Narodowy Instytut Onkologii im. Marii Skłodowskiej - Curie

Warsaw, Poland

ICO Hospitalet (Hospital Duran i Reynals)

Barcelona, Spain

Hospital Universitario Fundacion Jimenez Diaz

Madrid, Spain

Hospital Clinico Universitario de Salamanca

Salamanca, Spain

Hospital Universitario Virgen del Rocio

Seville, Spain

The Royal Marsden NHS Foundation Trust

Sutton, Surrey, United Kingdom

Beatson West of Scotland Cancer Centre

Glasgow, United Kingdom

University Hospitals of Leicester NHS Trust

Leicester, United Kingdom

UCLH NHS Foundation Trust

London, United Kingdom

The Christie NHS Foundation Trust

Manchester, United Kingdom

Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

Oxford University Hospitals NHS Foundation Trust

Oxford, United Kingdom